In this month’s episode of “Decoding Exits”, Vikram Gawande from Blume’s growth investment team highlights six PE/VC-backed companies that filed their DRHPs in August. From a founder who changed his name to sound more Italian, to Fractal Analytics' near-death experience while choosing a CEO, these stories are as compelling as their numbers.
Here is what you’ll find in this episode:
Fractal's AI Empire Expansion: ₹5,000 Cr IPO
From near-death experience to a ₹21,000 crore valuation, Fractal's remarkable turnaround story demonstrates the potential of India's enterprise AI capabilities.
Kissht Disrupts Traditional Lending: ₹1,650 Cr IPO
Breaking away from conventional CIBIL scores, Kissht's innovative 'Kissht Score' leverages social profiles and utility payments to democratise lending with a ~₹4,000 crore AUM.
Molbio's TB-Fighting Success Story: ₹1,400 Cr IPO
Recognised by WHO for their role in TB diagnosis, Molbio's journey from diagnostic innovation to a ₹12,500 crore valuation showcases India's healthcare technology leadership.
CleanMax's Green Energy Revolution: ₹5,200 Cr IPO
Transforming from a simple solar panel installer to a strategic CFO partner, CleanMax's innovative approach to renewable energy solutions is reshaping corporate sustainability.
Varmora’s Global Tile Empire: ₹1,050 Cr IPO
With Carlyle's backing and a strategic brand positioning, Varmora Granito has evolved into a major player in domestic and export markets for premium surfaces.
NephroPlus's Patient-First Innovation: ₹800 Cr IPO
Born from a patient's blog to India's leading dialysis chain, NephroPlus's journey showcases how personal experience can drive healthcare transformation.
Watch the full analysis to understand what these movements signal for founders and investors.
------------------------------------------
The views and opinions expressed in this content are for informational purposes only and do not constitute investment, legal, tax, or accounting advice, nor an offer or solicitation to buy or sell securities. References to companies, transactions, or market events are illustrative only and should not be construed as endorsements or statements of value. Any views expressed by individuals are solely their own and do not represent those of Blume Ventures, its affiliates, partners, or employees. Past performance is not indicative of future results.